2.69
Inmed Pharmaceuticals Inc Aktie (INM) Neueste Nachrichten
What analysts say about InMed Pharmaceuticals Inc. stockMarket-crushing profits - Autocar Professional
What drives InMed Pharmaceuticals Inc. stock priceExceptional return forecasts - Autocar Professional
Is InMed Pharmaceuticals Inc. a good long term investmentExceptional trading results - jammulinksnews.com
InMed Pharmaceuticals Inc. Stock Analysis and ForecastHigh-yield investments - jammulinksnews.com
InMed Pharmaceuticals (NASDAQ:INM) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
why inmed pharmaceuticals inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
Why InMed Pharmaceuticals Inc. stock attracts strong analyst attentionFree Stock Market Knowledge Sharing - Newser
How InMed Pharmaceuticals Inc. stock performs during market volatilityChart Breakout Alert - Newser
What makes InMed Pharmaceuticals Inc. stock price move sharply3x Return Stock Radar - Newser
InMed Pharmaceuticals Plunges 10.41% Amid Volatile Trading - AInvest
InMed Pharmaceuticals (INM) Files to Sell 3.9 Million Common Sha - GuruFocus
INMED PHARMACEUTIC (OTCMKTS:IMLFF) Is The Latest Cannabis Winner - Insider Financial
InMed Pharmaceuticals (NASDAQ:INM) Raised to “Sell” at Wall Street Zen - Defense World
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data - Benzinga
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules - Newsfile
InMed Pharmaceuticals Secures $5M Financing Deal with Potential $9.75M Total Value for Drug Development - Stock Titan
Cannabis Stocks To Watch Today – June 24th - Defense World
InMed Pharmaceuticals (INM) Secures Funding Through Private Plac - GuruFocus
InMed Pharmaceuticals’ Surprising Stock Rise: A Profitable Turn? - timothysykes.com
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study - Investing News Network
Inmed Pharmaceuticals Inc Amends Standby Equity Purchase Agreement With Yorkville - marketscreener.com
InMed Announces Auditor Change to CBIZ, Updates SEPA Agreement Terms | INM Stock News - Stock Titan
Transcript : InMed Pharmaceuticals Inc.Shareholder/Analyst Call - MarketScreener
Best Cannabis Stocks To Follow Now – June 2nd - Defense World
Top Premarket Gainers - MarketScreener
Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews
New CB1 and CB2 receptor modulators disclosed in Inmed patent - BioWorld MedTech
InMed Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks
Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022 - Seeking Alpha
InMed Pharmaceuticals (NASDAQ:INM) Trading Down 11.5% – Here’s What Happened - Defense World
Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews
Biotech Alert: Searches spiking for these stocks today - TipRanks
InMed Pharmaceuticals Advances Drug Pipeline Amid Financial Challenges - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):